OL投稿流程Word文件下载.docx
《OL投稿流程Word文件下载.docx》由会员分享，可在线阅读，更多相关《OL投稿流程Word文件下载.docx（10页珍藏版）》请在冰点文库上搜索。
Yourmanuscript
ManuscriptTitle:
****************************************wasreceivedintheeditorialofficesofOrganicLetterson10-MAR-05.
ThankyouforsubmittingyourworktoOrganicLetters.
SubmissionofamanuscripttoOrganicLettersimpliesthattheworkreported
thereinhasnotreceivedpriorpublicationandisnotunderconsiderationfor
publicationelsewhereinanymedium,includingelectronicjournalsandcomputer
databasesofapublicnature.Thismanuscriptisbeingconsideredwiththe
understandingitissubmittedonanexclusivebasis.Ifotherwise,pleaseadvise.
Whenyourmanuscripthasbeenassignedaneditor,youwillreceiveasecondemail
copyrightform.
IfyousubmittedthismanuscriptastheCorrespondingAuthor,youmayfindit
convenienttoshareyoursecuritykey.Thesecuritykeyallowsoneotherperson
tosubmitarevisiontothemanuscriptand/ortrackthemanuscript'
sstatuson
theirownParagonhomepage.
Ifthemanuscriptwassubmittedonyourbehalf,itsstatusdoesnotcurrently
displayonyourParagonhomepage.Usethesecuritykeytoaddthismanuscriptto
yourParagonhomepage.
PleaserememberthatonlytheCorrespondingAuthorandoneotherpersonmaytrack
amanuscript'
sstatusatonetime.
Sincerely,
Editor-in-Chief,OrganicLetter
一样翌日就会给你分主编,你能够进你的投稿主页上看到分配给你的主编.
这时,你的进美国化学会下载版权,签名后（要紧是第一作者和通讯作者）发往分配给你的主编.这一点专门重要,因为你不发版权,主编就可不能给你送审稿人!
!
第四
如果你在审稿期间通过系统跟踪你的文章
会有以下回复:
Thisemailistoinformyouthatthepersonwhoistrackingyourmanuscript"
************************************************"
************haschanged.
trackedby*****.
Pleaserememberthatonlytwopeople,theCorrespondingAuthorandoneother
person,maytrackamanuscriptatonetime.Ifyouchoosetoshareyour
manuscriptnumberandsecuritykeywithadditionalpartiesforthepurposeof
tracking,thenewerpartywilloverwriteanypreviouspersonwhowastrackingthe
manuscript.Newpartieswillnotoverwriteyourabilitytotrackyour
manuscript.
没有关系,意思是讲只承诺你和通讯作者跟踪文章
第五:
文章有消息（一样一个月）
DearProf.***:
YourpaperhasbeenreviewedandIwouldbehappytoacceptitafter
theattachedreviewercommentsandtheitemsindicatedontherevision
requestformhavebeenaddressed.Pleaseincludeadetailedletterwith
yourrevision,itemizingthechangesyouhavemadeinthemanuscript.
TOREVISEYOURMANUSCRIPTONTHEWEB:
-------------------------------------
NOTE:
PleasesubmityourrevisionusingyourParagonhomepage.
1.LogontoyourParagonhomepageathttp:
//paragon.acs.org.
2.Scrolltothesectiontitled:
'
Revisionsrequiredby
EditorialOffice.'
-Clickonthemanuscriptnumber*tosubmitarevision.
3.FollowthedirectionsinParagontocompletethesubmission
ofyourrevision.
[*Intheeventthismanuscriptisnotlistedonyourhomepage:
-Clickonthe'
ReviseManuscript'
buttontoaddthe
manuscripttoyourhomepageandrevisethemanuscript
-Enterthemanuscriptnumberandsecuritykeyasfollows:
ManuscriptNumber:
*******
NOTE:
Allmanuscriptnumbersbeginwiththeletters
ol'
followedby6numbers.Thelast
charactercanbeeitheraletter,anumber,
ora'
+'
sign.
SecurityKey:
******
-Clickon"
AddPaper"
-Themanuscriptshouldnowappearinthe
RevisionsrequiredbyEditorialOffice'
section
Continuewithsteps2and3above.]
SubmittingSupportingInformation（SI）:
AtStep3ofthesubmissionprocess,'
UploadDocuments'
youwillseea
listofalloftheSIfilesyouoriginallysubmitted.Youcanaddor
deletefiles.Ifyouhavechangedafile,youmustremoveitandupload
thenewversion.Youmustsubmitamanuscriptinordertosubmit
revisedSI.（Iftherearenochangestoyourmanuscript,simply
resubmittheoriginalmanuscript.）
Asyouknow,OrganicLettersaimsforquickturnaroundtimefrom
submissiontopublication;
therefore,weaskthatyoucompleteyour
revisionwithin7days.Pleaseletusknowifyouneedmoretime.We
willpublisharevisiondateifrevisiontakesover30days,unless
thereareextenuatingcircumstances.
审稿意见:
1#
RecommendationsregardingthemanuscriptMSNO:
***********
2.________Publishafterminorrevisionsnotedbelow
Overallimportanceofthispaper–8/10
Themanuscript**************by******andcoworkerssuggestsanovelmethodologyfor*******to*********8withlowligandloading.Thisworkcontributestoanintensivelyinvestigatedfieldofenantioselective************.Inparticular,additionof************stilllacksnoteworthyachievementsintermsofenantiomericpurityoftertiarypropargylicalcohols,obtainedinthistransformnation.Theligandsutilizedinthismanuscriptarestraightforwardlysynthesizedfromcommercialaminoacidsandusedinremarkablylowcatalyticquantities,ascomparedtothemethodsreportedsofar.Enantiomericpuritiesoffinalproductsaswellasisolatedyieldsareintherangeofreasonabletohigh.Thedescribedmethodologydoesn’trequireuseofadditionalLewisacid,thussimplifyingtheoverallprocess.Thediscussedmanuscriptisrecommendedforpublicationwithminorrevisionspresentedbelow.
Commentsreferringtothemanuscript:
·
Severalsentencesarebadformulatedandshouldbephraseddifferently
Severalgrammarmistakeswerefoundinthepresenttext
Severalmisspellingswerefoundinthereferencespartandshouldbeommited（i.e.,namesofjournalsaswellasnamesofauthors）
References9（k）wasnotfoundontheindicatedpage（JACS,2005,127,3137）.Thispaperappearsonthepage1313oftheindicatedissue.
Scheme2:
Itisrecommendedtoadd“R=***”and“R=*****”tothecompounds**and***respectively,tomaketheSchememoreclear
Ligand***appearsinFigure1,althoughnospeciesunderthisnumberarementionedinthetext
Table1–it’srecommendedtoaddafootnotewiththeamountofsubstrateusedinthistransformation,otherwisethestoichiometryofdiethylzincisunclear
Commentsreferringtotheexperimentalpart:
FromTable1onecanconcludethatthereactionisconductedat-18Cfor48h.Itappears,however,inthesyntheticprotocol,thatthereactionmixturewasactuallystirredatr.t.for********.
Formoreconvenientreadingandcorrelatingbetweenthedatainthetextandintheexperimentalpart,it’srecommendedtoassignnumberstotheobtainedproducts
ThechiralHPLCcolumnusedinthepresentworkforee%determinationismentionedasChiracelOD-Hinthetext,butChiracelODintheexperimentalpart
2#
ManuscriptNumber:
********
************
AlcoholsCorrespondingAuthor:
RatetheoverallimportanceofthispapertothefieldofOrganicChemistry
10-HighImportance/1-LowImportance:
8
Recommendation:
Publishafterminorrevisionsnotedbelow.
AdditionalComments:
Themanuscript"
*****************************"
by**************andcoworkerisaquiteinterestingandusefulpieceofwork.Wangandcoworkerswereabletofindasuitable,easilypreparedandinexpensiveligandthatmakepossibletheadditionofacetylidestoketonesinverylowloading.Theseareun-precedentresultsthatcouldopennewperspectiveintheformationofquaternarystereocenters.In-fact,animmediateextensiontothepresentcommunicationisthebehavioroftheligandsinadditionofsimple*******,functionalizedzincreagents,or*********8reagentsto********.Untilnow,onlyfewsuccessfulstudieshasbeenpublishedby****,*******and**********.************8'
sligandprobablycanbealsousedintheseprocesses,andtherefore,thispaperishighlyrecommendedforOrg.Lett.
Minorpoints.Inanoteacommentaboutthereactivityofaliphaticketonecouldbeusefultoreaders.
Innote,therearecorrectiontointroduce:
Reference1（b）.ComeprehensiveAsymmetricCatalysis.
Reference2（k）.Hems,andpublicationsyear2006.
Reference3（g）.************.;
Reference3（k）.*******.;
9（e）.Yorozu,K
Reference9（f）.Authorsaremissing:
（f）Belokon'
Y,R.;
Caveda-Cepas,S.;
Green,B.;
Ikonnikov,N.S.;
Khrustalev,V.N.:
Larichev,V.S.;
Moscalenko,M.A.;
North,M.;
Orizu,C.;
Tararov,V.I.;
Tasinazzo,M.;
TimofeevaG.I.,Yashkina,L.V.3968-3973.
Reference9（h）.Irvine,D.J.
Reference9（i）.KevinW.Kuntz.
Reference9（k）.J.Am.Chem.S
升级会员 